Preview

Osteoporosis and Bone Diseases

Advanced search

Relationship between bone mineral density, trabecular bone score and uric acid level in postmenopausal women with rheumatoid arthritis

https://doi.org/10.14341/osteo13198

Abstract

Background: uric acid (UA) is the end product of purine metabolism in humans. UA is considered as an antioxidant that prevents the negative effects of oxidative stress associated with aging and metabolic diseases. Some studies have shown both positive and negative associations between UA and bone mineral density (BMD) and its relationship with the trabecular bone score (TBS) is not fully understood.

Aim: to determine the relationship of BMD and TBS with UA level in postmenopausal women with rheumatoid arthritis (RA).

Materials and methods: the cross-sectional study included 140 postmenopausal women (median age 65.0 [59.5; 70.0] years) with a reliable diagnosis of RA. A unified questionnaire survey was conducted, a laboratory examination and dual-energy X-ray absorptiometry of femur and lumbar spine (L1-L4) with determination of TBS were performed.

Results: in the examined group, degraded microarchitecture was detected in 40.7% of patients, and the mean UA level was 273.9±73.7 mmol/L. Correlation analysis revealed a positive association between UA level and BMD of L1-L4 (r=0.025, p=0.003), total hip (TH) (r=0.23, p=0.007) and femoral neck (FN) (r=0,15, p=0,045) and a negative association with TBS (r=-0.18, p=0.035). Multiple linear regression revealed a significant positive association between BMD L1-L4 and TH with UA and body mass index (BMI), a negative association of BMD TH and TBS with age and UA level with TBS, while BMD FN was negatively associated with age and positively associated with BMI and calcium intake, but no relationship has been identified with UA.

Conclusion: our study showed an independent multidirectional relationship of UA level with BMD and TBS in postmenopausal women with RA: positive — with BMD L1-L4 and TH, negative — with TBS.

About the Authors

M. V. Kozyreva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

Maria V. Kozyreva – MD.

34A, Kashirskoye sh., Moscow, 115522

ResearcherID HHZ-3451-2022


Competing Interests:

None



O. V. Dobrovolskaya
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

Olga V. Dobrovolskaya - MD, PhD.

34A, Kashirskoye sh., Moscow, 115522

ResearcherID AAF-2921-2021; Scopus Author ID 57197823569


Competing Interests:

None



O. A. Nikitinskaya
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

Oksana A. Nikitinskaya - MD, PhD.

34A, Kashirskoye sh., Moscow, 115522

ResearcherID AAF-2616-2021; Scopus Author ID 6504217119


Competing Interests:

None



N. V. Toroptsova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

Natalia V. Toroptsova - MD, PhD.

34A, Kashirskoye sh., Moscow, 115522

ResearcherID I-9030-2017; Scopus Author ID 6507457856


Competing Interests:

None



References

1. Jin M, Yang F, Yang I et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci. 2012;17:656–669. doi: https://doi.org/10.2741/3950

2. Edwards NL. The role of hyperuricemia in vascular disorders [published correction appears in Curr Opin Rheumatol. 2010 Jan;22(1):107]. Curr Opin Rheumatol. 2009;21(2):132–137. doi: https://doi.org/10.1097/BOR.0b013e3283257b964

3. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr. Pharm. Des. 2005;11(32):4145–4151. doi: https://doi.org/10.2174/138161205774913255

4. Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation. 2002;105:2619-2624. doi: https://doi.org/10.1161/01.CIR.0000017502.58595.ED

5. Bowman GL, Shannon J, Frei B, et al. Uric acid as a CNS antioxidant. J Alzheimers Dis. 2010;19(4):1331–1336. doi: https://doi.org/10.3233/JAD-2010-1330

6. Paganoni S, Zhang M, Quiroz Zarate A, et al. Uric acid levels predict survival in men with amyotrophic lateral sclerosis. J Neurol. 2012;259:1923–1928. doi: https://doi.org/10.1007/s00415-012-6440-7

7. Agidigbi TS, Kim C. Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int. J. Mol. Sci. 2019;20(14):3576. doi: https://doi.org/10.3390/ijms20143576

8. Domazetovic V, Marcucci G, Iantomasi T, et al. Oxidative stress in bone remodeling: Role of antioxidants. Clin. Cases Miner. Bone Metab. 2017;14(2):209–216. doi: https://doi.org/10.11138/ccmbm/2017.14.1.209

9. Lean JM, Davies JT, Fuller K, et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest. 2003;112(6):915-923. doi: https://doi.org/10.1172/JCI18859

10. Lean JM, Jagger CJ, Kirstein B, et al. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinolo 2005;146:728–735. doi: https://doi.org/10.1210/en.2004-1021

11. Ahn SH, Lee SH, Kim B‐J, et al. Higher serum uric acid is associated with higher bone mass, lower bone turnover and lower prevalence of vertebral fracture in health postmenopausal women. Osteoporos Int. 2013;24:2961–70

12. Dalbeth N, Horne A, Mihov B, et al. Elevated urate levels do not alter bone turnover markers: Randomized controlled trial of inosine supplementation in postmenopausal women. Arthritis Rheumatol. 2021;73(9):1758–1764. doi: https://doi.org/10.1002/art.41691

13. Hu Z, Zhang L, Lin Z, et al. Prevalence and risk factors for bone loss in rheumatoid arthritis patients from South China: Modeled by three methods. BMC Musculoskelet. Disord. 2021;22(1):534. doi: https://doi.org/10.1186/s12891-021-04403-5

14. Li X, Li L, Yang L, et al. No association between serum uric acid and lumbar spine bone mineral density in US adult males: A cross-sectional study. Sci. Rep. 2021;11(1):15588. doi: https://doi.org/10.1038/s41598-021-95207-z

15. Dalle Carbonare L, Giannini S. Bone microarchitecture as an important determinant of bone strength. J. Endocrinol. Invest. 2004;27(1):99–105. doi: https://doi.org/10.1007/BF03350919

16. Harvey NC, Glüer CC, Binkley N, et al. Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone. 2015;78:216–224. doi: https://doi.org/10.1016/j.bone.2015.05.016

17. Pothuaud L, Carceller P, Hans D. Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: Applications in the study of human trabecular bone microarchitecture. Bone. 2008;42(4):775–787. doi: https://doi.org/10.1016/j.bone.2007.11.018

18. Silva BC, Leslie WD, Resch H et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image [published correction appears in J Bone Miner Res. 2017;32(11):2319] J. Bone Miner. Res. 2014;29(3):518–530. doi: https://doi.org/10.1002/jbmr.2176

19. Martineau P, Leslie WD, Johansson H, et al. Clinical utility of using lumbar spine trabecular bone score to adjust fracture probability: The Manitoba BMD cohort. J. Bone Miner. Res. 2017;32(7):1568–1574. doi: https://doi.org/10.1002/jbmr.3124

20. Li Y, Tan J, Tian J, et al. Cross-sectional analysis of the correlation between serum uric acid and trabecular bone score: NHANES 2005-2008. Sci Rep. 2023;13(1):21546. doi: https://doi.org/10.1038/s41598-023-48739-5

21. Fardellone P, Salawati E, Le Monnier L et al. Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review. J Clin Med. 2020;9(10):3361. Published 2020 Oct 20. doi: https://doi.org/10.3390/jcm9103361

22. Zhao C, Xiao Q, Huang W, et al. Association between rheumatoid arthritis and hyperuricemia among adults: a cross-sectional study based on NHANES data. Clin Rheumatol. Published online March 6, 2025. doi: https://doi.org/10.1007/s10067-025-07386-z

23. Lee HN, Kim A, Kim Y, Kim GT, Sohn DH, Lee SG. Higher serum uric acid levels are associated with reduced risk of hip osteoporosis in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore). 2020;99(24):e20633. doi: https://doi.org/10.1097/MD.0000000000020633

24. Veronese N, Carraro S, Bano G, et al. Hyperuricemia protects against low bone mineral density, osteoporosis and fractures: a systematic review and meta-analysis. Eur J Clin Invest. 2016;46(11):920-930. doi: https://doi.org/10.1111/eci.12677

25. Pirro M, Mannarino MR, Bianconi V, et al. Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat. Osteoporos Int. 2017;28(3):973-981. doi: https://doi.org/10.1007/s00198-016-3792-3

26. Tu J, Mo X, Zhang X, et al. BMI mediates the association of serum uric acid with bone heal th: a cross-sectional study of the National Health and Nutrition Examination Survey (NHANES). BMC Musculoskelet Disord. 2024;25(1):482. doi: https://doi.org/10.1186/s12891-024-07595-8

27. Toroptsova NV, Dobrovolskaya OV, Kozyreva MV, Demin NV. Is there an association between osteoporosis and uric acid? Rheumatology Science and Practice. 2024;62(6):622-626. (In Russ.). doi: https://doi.org/10.47360/1995-4484-2024-622-626

28. Han W, Bai X, Wang N, et al. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population. Arch Osteoporos. 2017;12(1):50. doi: https://doi.org/10.1007/s11657-017-0345-0


Supplementary files

Review

For citations:


Kozyreva M.V., Dobrovolskaya O.V., Nikitinskaya O.A., Toroptsova N.V. Relationship between bone mineral density, trabecular bone score and uric acid level in postmenopausal women with rheumatoid arthritis. Osteoporosis and Bone Diseases. 2025;28(2):4-10. (In Russ.) https://doi.org/10.14341/osteo13198

Views: 31


ISSN 2072-2680 (Print)
ISSN 2311-0716 (Online)